Unlocking Australia’s Medical Research Opportunity: How property strategy turns discovery into commercial growth
Australia’s medical research sector is world-class in discovery yet constrained by gaps in translation, infrastructure and commercialisation. Strong talent and research output exist, but challenges in scaling manufacturing, securing patient access pathways, building specialised facilities, and converting ideas into market-ready products create bottlenecks. These gaps also represent substantial commercial opportunity, particularly for those who can secure the right sites and deliver fit-for-purpose facilities efficiently.
At Mollard Property Group, we specialise in analytics-led Highest and Best Use (HBU) advisory and end-to-end development delivery. Our platform scores sites against more than 200 alternative uses, ranking them by financial viability, planning risk, execution time and much more. With over three decades of experience, more than 40 childcare projects, 30+ residential projects, a 100% planning approval success rate, and hundreds of millions in specialised social infrastructure delivered, we help clients de-risk decisions and unlock value across Australia.
Where the gaps create property opportunities
Key shortfalls in the medical field include limited sovereign manufacturing capacity for advanced therapies (cell and gene, mRNA, radiopharmaceuticals), fragmented clinical trial infrastructure, high barriers to commercialisation and patient access, and the need for integrated digital health and research spaces. Medical research institutes also face funding pressures, while workforce attraction depends on supporting amenities.
These translate into real estate needs:
- Purpose-built or adapted facilities for research labs, biotech incubators, GMP manufacturing, and clinical trial hubs.
- Commercial and mixed-use conversions near hospitals, universities, and research precincts.
- Supporting social infrastructure (including childcare and early learning) to attract and retain specialist talent.
- Sites that balance regulatory complexity, accessibility and long-term yield.
How Mollard Property Group assists interested parties
We work with investors, developers, research organisations, medtech operators, not-for-profits and commercial groups seeking to participate in this growth.
Our approach combines data-driven site intelligence with proven execution:
- Highest and Best Use analysis: We evaluate a site’s potential against medical, commercial, research, mixed-use and other supporting uses. This identifies the highest-viability path, whether a research facility, biotech conversion or complementary development, before capital is committed.
- Strategic site sourcing and acquisition: Using demographic, demand and planning data, we locate off-market and high-potential sites in growth corridors or near existing health and research clusters. We focus on locations that support both operational needs and investment returns.
- Feasibility and de-risking: Detailed financial modelling, planning pathway analysis and risk assessment ensure projects stack up. Our track record of 100% planning approval success reduces execution uncertainty.
- Design and development management: From concept through approvals and delivery, we provide end-to-end services. This includes adapting commercial or heritage assets, designing specialised spaces, and coordinating for compliance and efficiency.
- Social infrastructure alignment: Our deep expertise in preschool and early learning centres supports workforce strategies for medical and research hubs, creating integrated precincts that enhance liveability and operational success.
- Flexible engagement: Whether full turnkey delivery, advisory on an existing site, joint venture structuring, or leasing solutions for operators, we tailor support to the client’s objectives.
A practical pathway forward
For parties interested in the commercial potential of Australia’s medical research strengths, whether as investors seeking resilient assets, operators needing specialised facilities, or developers targeting high-demand sectors, the critical first step is rigorous site and use analysis and property analytics. Property decisions made without this data often become expensive mistakes; those backed by analytics and specialist delivery tend to capture the opportunity.
Mollard Property Group combines spatial intelligence with on-the-ground development expertise to help clients identify, secure and deliver assets that align with emerging demand in health, research, and related commercial uses. If you are exploring opportunities in this space, we invite you to discuss how our HBU engine and delivery capabilities can support your strategy.
Contact Mollard Property Group to arrange a confidential briefing on site potential, feasibility, or development pathways. Our team is ready to help turn identified opportunity into a de-risked, high-performing outcome.